MLTX - CIK 0001821586
MoonLake Immunotherapeutics has filed 296 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (67 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2023-06-07 | 2023-06-07 |
| Major company event | 8-K | 2023-05-19 | 2023-05-15 |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Prospectus supplement | 424B5 | 2023-05-11 | - |
| EFFECT | - | 2023-05-09 | - |
| Company correspondence | CORRESP | 2023-05-05 | - |
| EFFECT | - | 2023-05-04 | - |
| SEC correspondence | UPLOAD | 2023-05-04 | - |
| Securities registration | S-3 | 2023-05-01 | - |
| POS AM | - | 2023-05-01 | - |
| Annual report to shareholders | ARS | 2023-04-26 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-04-26 | - |
| Proxy statement | DEF 14A | 2023-04-26 | 2023-06-07 |
| Major company event | 8-K | 2023-04-19 | 2023-04-19 |
| Insider trade | 4 | 2023-04-07 | 2023-04-05 |
| Insider trade | 4 | 2023-04-07 | 2023-04-05 |
| Passive ownership stake | SC 13G | 2023-03-31 | - |
| 424B3 | - | 2023-03-28 | - |
| EFFECT | - | 2023-03-27 | - |
| Insider trade | 4 | 2023-03-22 | 2023-03-20 |
| Annual report | 10-K | 2023-03-20 | 2022-12-31 |
| Major company event | 8-K | 2023-03-20 | 2023-03-20 |
| POS AM | - | 2023-03-20 | - |
| Major company event | 8-K | 2023-03-10 | 2023-03-10 |
| Passive ownership stake (update) | SC 13G/A | 2023-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-01-27 | - |
| Quarterly report | 10-Q | 2022-11-14 | 2022-09-30 |
| 424B3 | - | 2022-11-14 | - |
| Employee stock plan | S-8 | 2022-09-30 | - |
| Quarterly report | 10-Q | 2022-08-12 | 2022-06-30 |
| 424B3 | - | 2022-08-12 | - |
| Passive ownership stake | SC 13G | 2022-08-03 | - |
| EFFECT | - | 2022-08-02 | - |
| 424B3 | - | 2022-08-02 | - |
| Company correspondence | CORRESP | 2022-07-29 | - |
| Company correspondence | CORRESP | 2022-07-26 | - |
| S-1/A | - | 2022-07-26 | - |
| SEC correspondence | UPLOAD | 2022-07-21 | - |
| Company correspondence | CORRESP | 2022-07-15 | - |
| S-1/A | - | 2022-07-15 | - |
| Major company event | 8-K | 2022-06-17 | 2022-06-15 |
| Major company event | 8-K | 2022-06-07 | 2022-06-07 |
| Major company event (amended) | 8-K/A | 2022-05-16 | 2022-04-05 |
| Quarterly report | 10-Q | 2022-05-16 | 2022-03-31 |
| SEC correspondence | UPLOAD | 2022-05-16 | - |
| Insider trade | 4 | 2022-05-05 | 2022-04-06 |
| Insider trade | 4 | 2022-05-05 | 2022-04-06 |